Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion
Journal of Interventional Cardiology · 03.03.2021 · 2021 · 1-7
DOI: 10.1155/2021/5529317 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Interventional Cardiology, erschienen am 03.03.2021. Verfasst von Norihiro Kobayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
We aimed to evaluate the efficacy of stentless strategy by drug-coated balloon (DCB) angioplasty following directional coronary atherectomy (DCA) for left main (LM) bifurcation lesions.
Methods
A total of 38 patients who underwent DCB angioplasty following DCA for LM bifurcation lesions were retrospectively enrolled. The primary endpoint was target vessel failure (TVF) at 12 months. Secondary endpoints included procedure-related major events during the hospitalization, major adverse cardiac events at 12 months, ischemia-driven target lesion revascularization (TLR) at 12 months, and bleeding complications defined as the Bleeding Academic Research Consortium criteria ≥2 at 12 months.
Results
Among these 38 lesions, 31 lesions were de novo LM bifurcation lesions and 7 lesions were stent edge restenosis at the left anterior descending (LAD) ostium. The mean % plaque area (%PA) after DCA was 44.0 ± 7.4%. TVF at 12 months occurred in 1 lesion (3.2%) of de novo LM bifurcation lesion and in 3 lesions (42.9%) of stent edge restenosis at the LAD ostium. All events of TVF were ischemia-driven TLR by percutaneous coronary intervention. Among 4 TLR cases, %PA after DCA was high (55.9%) in the de novo LM bifurcation lesions; on the other hand, %PA after DCA was low (42.4%, 38.7%, and 25.7% in the 3 cases) in stent edge restenosis at the LAD ostium. No procedure-related major events were observed during hospitalization. There was no cardiac death, no myocardial infarction, no coronary artery bypass grafting, and no bleeding complications at 12 months.
Conclusions
Stentless strategy by DCB angioplasty following DCA for de novo LM bifurcation lesions resulted in acceptable outcomes. On the other hand, its efficacy was limited for stent edge restenosis at the LAD ostium even after aggressive debulking by DCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan.
ORCID-Profile: Norihiro Kobayashi, Shinsuke Mori, Yohsuke Honda
Zitieren
APA
Kobayashi, N., Yamawaki, M., Mori, S., Tsutsumi, M., Honda, Y., Makino, K., Shirai, S., Mizusawa, M., & Ito, Y. (2021). Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion. Journal of Interventional Cardiology, 2021, 1-7. https://doi.org/10.1155/2021/5529317
Vancouver
Kobayashi N, Yamawaki M, Mori S, Tsutsumi M, Honda Y, Makino K, et al. Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion. Journal of Interventional Cardiology. 2021;2021:1-7. doi:10.1155/2021/5529317
BibTeX
@article{Kobayashi2021,
author = {Kobayashi, Norihiro and Yamawaki, Masahiro and Mori, Shinsuke and Tsutsumi, Masakazu and Honda, Yohsuke and Makino, Kenji and Shirai, Shigemitsu and Mizusawa, Masafumi and Ito, Yoshiaki},
title = {Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion},
journal = {Journal of Interventional Cardiology},
year = {2021},
volume = {2021},
pages = {1--7},
doi = {10.1155/2021/5529317}
}
EUVIMED